Champions Oncology (CSBR) Non-Current Assets (2011 - 2026)

Champions Oncology has reported Non-Current Assets for 16 years, with the latest figure at $7.8 million in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 22.19% year-over-year to $7.8 million in Q2 2026; TTM through Apr 2026 was $34.4 million, a 21.52% decrease from a year earlier, with the FY2026 full-year figure at $7.8 million, down 22.19% from the prior year.
• Non-Current Assets was $7.8 million for Q2 2026 at Champions Oncology, down from $8.3 million in the prior quarter.
• The five-year high for Non-Current Assets was $16.0 million in Q3 2022, with the low at $7.8 million in Q2 2026.
• Average Non-Current Assets over 5 years is $12.6 million, with a median of $13.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Non-Current Assets soared 39.57% in 2022, then slipped 24.41% in 2026.
• Over 5 years, Non-Current Assets stood at $15.8 million in 2022, then fell by 9.39% to $14.3 million in 2023, then slipped by 21.86% to $11.2 million in 2024, then decreased by 20.85% to $8.8 million in 2025, then decreased by 12.0% to $7.8 million in 2026.
• The last three Non-Current Assets figures came in at $7.8 million (Q2 2026), $8.3 million (Q1 2026), and $8.8 million (Q4 2025), per Business Quant data.